A Rat Model of Ascending Uncomplicated Urinary Tract Infection for Anti-Infective Efficacy Studies
Abstract
Abstract Urinary tract infections (UTIs) are among the most prevalent bacterial infections worldwide and contribute substantially to antimicrobial resistance, highlighting the need for robust preclinical models to support development of novel anti‑infective therapies. Although mouse models dominate UTI research, anatomical and technical constraints can limit translational pharmacokinetic and pharmacodynamic (PK/PD) studies, particularly for intravenously administered agents. Here, we describe and validate an ascending model of uncomplicated UTI in adult female Wistar rats that enables reproducible bladder and kidney infection and supports comprehensive treatment evaluation. Transurethral catheterization was used to inoculate the bladder with the well‑characterized uropathogenic Escherichia coli strain CFT073. Compared with Sprague Dawley rats, Wistar rats exhibited more stable infection kinetics and lower intra‑group variability and were therefore selected for model optimization. Enrichment of type 1 fimbriae expression significantly enhanced bladder colonization, urinary bacterial shedding, and ascending infection of the kidneys. Using this optimized model, a single intravenous dose of ciprofloxacin produced rapid bactericidal activity within two hours of treatment and sustained efficacy, with three to four log reductions in bacterial burdens in urine, bladder, and kidneys at twenty‑four hours post‑treatment. Histopathological analysis demonstrated infection‑associated…
How strong is the evidence?
Evidence Hub reads this as a preprint, done in animal, not in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Horizontal gene transfer in the human gastrointestinal tract: potential spread of antibiotic resistance genes
- Mutation supply and relative fitness shape the genotypes of ciprofloxacin-resistant Escherichia coli
- Genomic Survey of E. coli From the Bladders of Women With and Without Lower Urinary Tract Symptoms
- Characterization of cefotaxime-resistant urinary Escherichia coli from primary care in South-West England 2017–18
- Fitness cost constrains the spectrum of marR mutations in ciprofloxacin-resistant Escherichia coli
- Emerging evidence-based innovative approaches to control catheter-associated urinary tract infection: a review
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.